Look Forward – Winter 2022 – Issue 178
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
Search
Search results
Our community
We are nothing without our amazing community. They are the reason we do what we do and are a constant source of inspiration to us.
Stem cells
Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).
Encouraging results from ProQR USH2A clinical trial
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Types of inherited sight loss
Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.
e-Newsletter May 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Get involved
Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.
‘Talking’ Tech Peer Support Group
Thursday 15 May 2025, 7.00pm - 8.00pm - via Zoom - Come and join us for our latest meeting where we will be joined by our guest speakers and new sponsors, EMVI - A Mobile Visual Assistant Designed by and for the Visually Impaired.
Gene therapy shows promise in tackling X-linked RP
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.